Effect of medium- and long-chain triglycerides on lower esophageal sphincter pressure: Role of CCK

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 274, Issue 6 37-6, 1998, Pages

  Ledeboer, M ^a   Masclee, A A M ^a   Biemond, I ^a   Lamers, C B H W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cholecystokinin receptor antagonist; Dietary fat; Esophageal motility; Gallbladder motility

Indexed keywords

CHOLECYSTOKININ; LONG CHAIN FATTY ACID; LOXIGLUMIDE; MEDIUM CHAIN FATTY ACID;

ADULT; ARTICLE; DIETARY INTAKE; FEMALE; GALLBLADDER; HUMAN; HUMAN EXPERIMENT; LIPID ANALYSIS; LIPID DIET; LOWER ESOPHAGUS SPHINCTER; MALE; MANOMETRY; NORMAL HUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0031798781     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1998.274.6.g1160     Document Type: Article

References (36)

1. Abrams, C. K., M. Hamosh, and S. K. Dutta. Role of nonpancreatic lipolytic activity in exocrine pancreatic insufficiency. Gastroenterology 92: 125-129, 1987.
2. Adler, G., and C. Beglinger. Cholecystokinin Antagonists in Gastroenterology. Berlin: Springer-Verlag, 1991, p. 1-233.
3. Babka, J. C., and D. O. Castell. On the genesis of heartburn, the effects of specific foods on the lower esophageal sphincter. Am. J. Dig. Dis. 18: 391-396, 1973.
4. Biancani, P., M. C. Beinfeld, C. Hillemeier, and J. Behar. Role of peptide histidine isoleucine in relaxation of cat lower esophageal sphincter. Gastroenterology 97: 1083-1089, 1989.
5. Biancani, P., J. H. Walsh, and J. Behar. Vasoactive intestinal polypeptide: a neurotransmitter for lower esophageal sphincter relaxation. J. Clin. Invest. 73: 963-967, 1984.
6. Borody, T., D. J. Byrnes, and L. Henderson. Molecular forms of CCK in human postprandial plasma (Abstract). Gastroenterology 86: 1032, 1984.
7. Brazer, S. R., D. S. Borislow, and R. A. Liddle. Cholecystokinin is not a major hormonal regulator of lower esophageal sphincter pressure. Gastroenterology 99: 641-645, 1990.
8. Casaubon, P. R., K. A. Dahlstrom, J. Vargas, R. Hawkins, M. Mogard, and M. E. Ament. Intravenous fat emulsion (Intralipid) delays gastric emptying, but does not cause gastroesophageal reflux in healthy volunteers. JPEN J. Parenter. Enteral Nutr. 13: 246-248, 1989.
9. Dent, J. A new technique for continuous sphincter pressure measurement. Gastroenterology 71: 263-267, 1976.
10. Douglas, B. R., M. C. W. Jebbink, R. T. O. Tjon a Tham, J. B. M. J. Jansen, and C. B. H. W. Lamers. The effect of loxiglumide (CR-1505) on basal and bombesin-stimulated gallbladder volume in man. Eur. J. Pharmacol. 166: 307-310, 1989.
11. Everson, G. T., D. Z. Braverman, M. L. Johnson, and F. Kern. A critical evaluation of real-time ultrasonography for the study of gallbladder volume and contraction. Gastroenterology 79: 40-46, 1980.
12. Fisher, R. S., A. J. Dimarino, and S. Cohen. Mechanism of cholecystokinin inhibition of lower esophageal sphincter pressure. Am. J. Physiol. 228: 1469-1473, 1975.
13. Guedon, G., P. Ducrotte, J. A. Chayvialle, E. Lerebours, P. Denis, and R. Colin. Effects of intravenous and intraduodenal fat on jejunal motility and on plasma cholecystokinin in man. Dig. Dis. Sci. 33: 358-364, 1988.
14. Hildebrand, P., C. Beglinger, K. Gyr, J. B. M. J. Jansen, L. C. Rovati, M. Zuercher, C. B. H. W. Lamers, I. Setnikar, and G. A. Stalder. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man. J. Clin. Invest. 85: 640-646, 1990.
15. Hölzer, H. H., and H. E. Raybould. Vagal and splanchnic sensory pathways mediate inhibition of gastric motility induced by duodenal distension. Am. J. Physiol. 262 (Gastrointest. Liver Physiol. 25): G603-G608, 1992.
16. Hopman, W. P. M., W. F. M. Brouwer, G. Rosenbusch, J. B. M. J. Jansen, and C. B. H. W. Lamers. A computerized method for rapid quantification of gallbladder volume from real-time sonograms. Radiology 154: 230-237, 1985.
17. Hopman, W. P. M., J. B. M. J. Jansen, and C. B. H. W. Lamers. Comparative study of the effects of equal amounts of fat, protein and starch on plasma cholecystokinin in man. Scand. J. Gastroenterol. 20: 843-847, 1985.
18. Hopman, W. P. M., J. B. M. J. Jansen, G. Rosenbusch, and C. B. H. W. Lamers. Effect of equimolar amounts of long-chain triglycerides and medium chain triglycerides on plasma cholecystokinin and gallbladder contraction. Am. J. Clin. Nutr. 39: 356-359, 1984.
19. Isaacs, P. E. T., S. Ladas, I. C. Forgacs, R. H. Dowling, S. V. Ellam, T. O. Adrian, and S. R. Bloom. Comparison of effects of ingested medium- and long-chain triglyceride on gallbladder volume and release of cholecystokinin and other gut peptides. Dig. Dis. Sci. 32: 481-486, 1987.
20. Jansen, J. B. M. J., M. C. W. Jebbink, B. R. Douglas, and C. B. H. W. Lamers. Effect of loxiglumide (CR-1505) on bombesin- and meal-stimulated plasma cholecystokinin release in man. Eur. J. Pharmacol. 28: 367-370, 1990.
21. Jansen, J. B. M. J., and C. B. H. W. Lamers. Radioimmunoassay of cholecystokinin in human tissue and plasma. Clin. Chim. Acta 131: 305-316, 1983.
22. Jansen, J. B. M. J., and C. B. H. W. Lamers. Molecular forms of cholecystokinin in plasma from normal and gastrectomized subjects following a fat meal. Peptides 8: 801-805, 1987.
23. Jebbink, M. C. W., J. B. M. J. Jansen, D. M. Mooy, L. C. Rovati, and C. B. H. W. Lamers. Effect of the specific cholecystokinin-receptor antagonist loxiglumide on bombesin-stimulated pancreatic enzyme secretion in man. Regul. Pept. 32: 361-368, 1991.
24. Jensen, D. M., R. W. McCallum, E. Corazziari, J. Elashoff, and J. H. Walsh. Human lower esophageal sphincter responses to synthetic human gastrins 34 (G-34) and 17 (G-17). Gastroenterology 79: 431-438, 1980.
25. Katschinski, M., J. Schirra, T. Koppelberg, R. Arnold, L. C. Rovati, C. Beglinger, and G. Adler. Effect of cholecystokinin-A-receptor blockade on oesophageal motility. Eur. J. Gastroenterol. Hepatol. 6: 983-989, 1994.
26. Ledeboer, M., A. A. M. Masclee, M. R. Batstra, J. B. M. J. Jansen, and C. B. H. W. Lamers. Effect of cholecystokinin on lower oesophageal sphincter pressure and transient lower oesophageal sphincter relaxations in humans. Gut 36: 39-44, 1995.
27. Liddle, R. A., I. D. Goldfine, M. S. Rosen, R. A. Taplitz, and J. A. Williams. Cholecystokinin bioactivity in human plasma: molecular forms, responses to feeding, and relation to gallbladder contraction. J. Clin. Invest. 75: 1144-1152, 1985.
28. Maas, M. I. M., W. P. M. Hopman, M. B. Katan, and J. B. M. J. Jansen. Release of peptide YY and inhibition of gastric acid secretion by long-chain and medium-chain triglycerides but not by sucrose polyester in men. Eur. J. Clin. Invest. 28: 123-130, 1998.
29. Masclee, A. A. M., J. B. M. J. Jansen, L. C. Rovati, and C. B. H. W. Lamers. Effect of cholestyramine and cholecystokinin-receptor antagonist CR-1505 (loxiglumide) on lower esophageal sphincter pressure in man. Dig. Dis. Sci. 38: 1889-1892, 1993.
30. Meyer, B. M., B. A. Werth, C. Beglinger, P. Hildebrand, J. B. M. J. Jansen, D. Zach, L. C. Rovati, and G. A. Stalder. Role of cholecystokinin in the regulation of gastrointestinal motor functions. Lancet 2: 12-15, 1989.
31. Moreau, J., M. Bouisson, and D. Balas. Gastric lipase in alcoholic pancreatitis: comparison of secretive profiles following pentagastrin stimulation in normal adults and patients with pancreatic insufficiency. Gastroenterology 99: 175-180, 1990.
32. Nebel, O. T., and D. O. Castell. Lower esophageal sphincter pressure changes after food ingestion. Gastroenterology 63: 778-783, 1972.
33. Resin, H., D. H. Stern, R. A. L. Sturdevant, and J. I. Isenberg. Effect of the C-terminal octapeptide of cholecystokinin on lower esophageal sphincter pressure in man. Gastroenterology 64: 946-949, 1973.
34. Setnikar, B. I., M. Bani, R. Cereda, R. Chisté, F. Makovec, M. A. Pacini, L. Revel, L. C. Rovati, and L. A. Rovati. Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonist. Arzneim. Forsch. 37: 703-707, 1987.
35. Sturdevant, R. A. L., and T. Kun. Interaction of pentagastrin and the octapeptide of cholecystokinin on the human lower esophageal sphincter. Gut 15: 700-702, 1974.
36. Verkijk, M., J. Vecht, H. A. J. Gielkens, C. B. H. W. Lamers, and A. A. M. Masclee. Effects of medium-chain and long-chain triglycerides on antroduodenal motility and small bowel transit time in man. Dig. Dis. Sci. 42: 1933-1939, 1997.